X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CONTROLLED RELEASE

期刊標題檢索 J CONTROL RELEA 最新評論: 10-18, editor invited 10-22, with editor 10-23, under review 11-03... (2024-11-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CONTROLLED RELEASE]您好,您是該頁面的第 265009 位訪客。

期刊簡介
期刊名稱JOURNAL OF CONTROLLED RELEASE JOURNAL OF CONTROLLED RELEASE
LetPub Score
9.1
50 ratings
Rate

Reputation
9.8

Influence
8.8

Speed
8.7

期刊簡稱J CONTROL RELEASE
ISSN0168-3659
E-ISSN1873-4995
h-index237
CiteScore
CiteScoreSJRSNIPCiteScore Rank
18.502.1571.559
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q13 / 183

自引率 (2023-2024)3.80%自引率趨勢
掲載範囲
The Journal of Controlled Release (JCR) publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Manuscripts that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority. Each issue has the cover story highlighting the significance of a selected article published in the issue. At the end of each quarter, the JCR editors select "The Editors' Choice" from the published research articles.
官方網站https://www.journals.elsevier.com/journal-of-controlled-release
在線稿件提交https://www.editorialmanager.com/COREL
開放訪問No
出版商Elsevier
主題領域医学
出版國/地區NETHERLANDS
發行頻率月2回刊行
創刊年1984
每年文章數645每年文章數趨勢
黃金OA百分比22.04%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MULTIDISCIPLINARYSCIEQ126/230
PHARMACOLOGY & PHARMACYSCIEQ112/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0168-3659%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 2.6 month(s)
來自Elsevier的數據: Average 6.2 Week(s)
競爭力 *來自作者的數據: 50%
在線文章發布時間來自Elsevier的數據: Average 6.2 Week(s)
參考鏈接
相關期刊 【JOURNAL OF CONTROLLED RELEASE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CHEMICAL REVIEWSH-index: 609

    CiteScore: 106.00
    CHEMICAL SOCIETY REVIEWSH-index: 432

    CiteScore: 80.80
    Nature ChemistryH-index: 187

    CiteScore: 29.60
    ACCOUNTS OF CHEMICAL RESEARCHH-index: 354

    CiteScore: 31.40
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITIONH-index: 482

    CiteScore: 26.60
    Journal of the American Chemical SocietyH-index: 542

    CiteScore: 24.40
    CHINESE CHEMICAL LETTERSH-index: 41

    CiteScore: 14.10
    GREEN CHEMISTRYH-index: 186

    CiteScore: 16.10
    ULTRASONICS SONOCHEMISTRYH-index: 109

    CiteScore: 15.80
    ChemSusChemH-index: 130

    CiteScore: 15.80
    學科內最受檢索的期刊 頁面查看次數
    CHEMICAL COMMUNICATIONS1242076
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES1241812
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION1080535
    Journal of the American Chemical Society839891
    GREEN CHEMISTRY675398
    NEW JOURNAL OF CHEMISTRY666420
    CHEMISTRY-A EUROPEAN JOURNAL500746
    CHINESE CHEMICAL LETTERS496571
    ChemSusChem468021
    CRYSTENGCOMM369659
  •  

    JOURNAL OF CONTROLLED RELEASE JOURNAL OF CONTROLLED RELEASE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [JOURNAL OF CONTROLLED RELEASE] 的評論撰寫評論
作者: Jamie0703


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-06 23:59:03 評論於
10-18, editor invited
10-22, with editor
10-23, under review
11-03, invited 3 people, 2 accepted and submitted comments 2/2/3, required review complete
11-06, under review, this is under review again.
(0) 讚! | Jamie0703

作者: Jamie0703


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 20:16:11 評論於
10-18, editor invited
10-22, with editor
10-23, Under Review
(0) 讚! | Jamie0703

作者: John china


領域: 农林科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-21 11:59:16 評論於
Is it under review now?
(0) 讚! | John china

作者: Jamie0703


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-16 00:16:00 評論於
Record the status:
10-12, submitted
10-15, with editor, assigned manuscript number
(0) 讚! | Jamie0703

作者: 缺月疏桐


領域: 医学
審稿時間: 4.0 month(s)
結果: 直接被接受


撰寫評論

2024-10-03 09:33:53 評論於
The submission system of Elsevier allows you to track the status of your submission to the Journal of Controlled Release. This email subject for corresponding authors can provide information on the editing process, status of reviewer invitations (how many have been invited, accepted or declined, and how many reviews have been received), all of which will keep you informed about the status of your manuscript.
(0) 讚! | 缺月疏桐

作者: ajiejiejie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-28 06:04:53 評論於
Around 7.20 submitted; received the results on 9.2, with two minor revisions, returned on 9.10, and it's still in the hands of the editor as of today, 9.28... Not sure if it's because the JCR processing speed has always been slow, or if they are just being cautious and looking for another reviewer. Can any experienced experts provide some insight? Thank you.
(0) 讚! | ajiejiejie

作者: 缺月疏桐


領域: 医学
審稿時間: 4.0 month(s)
結果: 直接被接受


撰寫評論

2024-09-16 08:45:29 評論於
If it is targeted drug delivery, it requires novelty in chemical synthesis, innovation in responsive release, a high demand for clinical disease treatment, and novelty in disease models. Achieving these aspects will lead to rapid acceptance. Otherwise, like my article, it will be slow and difficult to find reviewers.
(1) 讚! | 缺月疏桐

作者: 缺月疏桐


領域: 医学
審稿時間: 4.0 month(s)
結果: 直接被接受


撰寫評論

2024-09-15 14:35:23 評論於
Record the experience of submitting a paper! The submission to Science Advances was rejected, and the editor recommended submitting to JCR. On May 12, 2024, the paper was submitted to the journal, with the editor assigned on May 20. On May 28, the paper was under review, with 2 reviews completed. 3 review invitations were accepted and 3+ review invitations were sent. This status lasted for one month before the review was completed on June 20. A revision was submitted on July 20 and reviews were completed on August 10, with 1 review invitation accepted and 2 review invitations sent (PS During the major revision, there were 3 reviewers, 1 acceptance, and 2 modifications). On September 14, there was a reminder for some new reviews for COREL-D-24-01810R1 in "Peer review status", and I recommended additional reviewers. The paper was accepted on September 15.
(1) 讚! | 缺月疏桐

作者: 缺月疏桐


領域: 医学
審稿時間: 4.0 month(s)
結果: 直接被接受


撰寫評論

2024-09-15 14:35:03 評論於
This is the first time submitting an article to JCR, which is said to be the top journal in pharmacy, so I have high expectations.
(1) 讚! | 缺月疏桐

作者: Cassatt


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2024-09-05 09:49:18 評論於
4.17 submit
4.22 editor invited
4.23 under review
5.2 under review
6.2 under review
6.12 under review
6.22 revise
9.3 accept
(0) 讚! | Cassatt

作者: plain river


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-24 11:30:53 評論於
Submitted in March, accepted in July, featured article!
(0) 讚! | plain river

作者: lec


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-06 16:04:02 評論於
Apr 22, 2024 Submitted to Journal
Apr 24, 2024 With Editor
Apr 25, 2024 Under Review
Apr 30, 2024 Required Reviews Completed 1/4
May 04, 2024 Required Reviews Completed 2/4
May 09, 2024 Required Reviews Completed 3/4
May 14, 2024 Required Reviews Completed 4/4
May 20, 2024 Decision in Process

1st revision
Jul 09, 2024 With Editor
Jul 10, 2024 With Editor
Jul 13, 2024 Accept (Editor accepted directly, no further revisions required)
(0) 讚! | lec

作者: 云枫


領域: 化学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-30 15:50:37 評論於
What is the final result?
(0) 讚! | 云枫

作者: Yehudi Luke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-13 12:22:49 評論於
Have you resolved this issue? Thank you.
(0) 讚! | Yehudi Luke

作者: 小宇宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-08 14:29:25 評論於
Hahaha, accept.
(0) 讚! | 小宇宇

作者: 蛇骨97


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-23 22:18:40 評論於
2024-1-9 submitted
2024-1-17 with editor
2024-1-20 under review
2024-2-19 revise
2024-4-12 revise submitted
2024-6-22 accepted
(0) 讚! | 蛇骨97

作者: Rachel Roy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-20 14:07:21 評論於
May I ask what the status was before "under review"?
(0) 讚! | Rachel Roy

作者: 半π


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-05-31 08:38:27 評論於
The content of the submission is new in terms of technical aspects, material construction strategies, and the effects of formulation use. After submission, two of the three reviewers suggested minor revisions, but the third reviewer harshly criticized the manuscript, saying it was all rubbish, and then said, "Using cellulose acetate as a drug carrier, and cellulose acetate cannot degrade, so it cannot be used for oral nanodrugs. The manuscript should be rejected directly." The Korean-American female editor at Stanford University also rejected the manuscript because of this. Malicious reviewers (from the mainland) + ignorant editors have made me lose my desire to argue. The journal circle is deep and unpredictable; I must henceforth be a passerby!
(0) 讚! | 半π

作者: 豆子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-21 10:30:43 評論於
How did the article turn out in the end?
(0) 讚! | 豆子

作者: asd3204


領域: 医学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2024-05-18 20:58:57 評論於
This has already been rejected, there is no need to hold on to any illusions, DIP before the submission has no exceptions
(1) 讚! | asd3204

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-14 16:17:38 評論於
Will the decision continue to be in process before under review? Hahaha
(0) 讚! | Kingsley791

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-14 16:16:41 評論於
First-time submission with editor, decision in process for 7 days now. Haha, is this the process of rejection or just the state before the reviewer accepts the manuscript? Haha, keep going, good luck
(0) 讚! | Kingsley791

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-09 16:57:56 評論於
Basking in happiness will bring you good luck
(0) 讚! | Kingsley791

作者: Kingsley791


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2024-05-09 16:57:00 評論於
Soak up the joy and cheer yourself on!
(0) 讚! | Kingsley791

作者: ZNNBB


領域: 工程技术
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-02 20:10:04 評論於
Submitted in early February, received the first review result in about four weeks. The revised manuscript was received three weeks after submission. The editorial process was efficient, and the reviewers' comments were very professional
(0) 讚! | ZNNBB

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [JOURNAL OF CONTROLLED RELEASE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*